ABI Innovation: doseR: a novel framework for dosage compensation and global expression analysis
ABI Innovation: doseR: a novel framework for dosage compensation and global expression analysis
批准号:
1661454
负责人:
James Walters
金额:
$77.53万
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-08-01 至 2023-07-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This research aims to develop and make broadly available a novel statistical methodology for analyzing patterns of gene expression that result from differences in chromosome copy number, in particular as arise on the sex-chromosomes (e.g. XX females versus XY males). Often a difference in chromosome copy number, which causes a difference in gene dose for those chromosomes, results in a corresponding effect on gene expression, termed a "dosage effect". However, in many organisms, special "dosage compensation" mechanisms have evolved to mitigate these dosage effects arising from differences in chromosome copies, such as between males and females on the sex-chromosomes. There is increasing interest in understanding which organisms employ dosage compensation mechanisms, and why. Recent advances in genome-wide assays of gene expression have greatly expanded which taxa can be assayed for dosage compensation, but analytical approaches for such data are varied, inconsistently applied, and typically do not make full use of the information available in the data. The methods and software developed from this project, called "doseR", will provide a cohesive and comprehensive solution to each of these issues. As such, the "doseR" project fills a major gap that currently exists in analytical methods for genomic investigations of dosage compensation. Furthermore, beyond dosage compensation analysis, this methodology can be generalized to identify broad shifts in gene expression between groups of genes that arise under different biological conditions. Thus, development and deployment of doseR will bridge the gap between biological intuition and bioinformatic inference, not only for dosage compensation, but also for many still as yet unforeseen lines of inquiry. This project also creates several training opportunities for undergraduate students, including intensive bioinformatic training workshops and direct participation in research activities.This research aims to develop and make broadly available a novel linear-modeling statistical methodology for analyzing sex-chromosome dosage compensation using genome-wide RNA-seq expression data. The statistical approaches currently employed for such analyses are far from ideal given the nature of the data and the desired set of inferences. Currently, biological replicates are averaged into a single measurement per gene and heavily normalized. Then particular effects of gene expression on the sex-chromosome relative to autosomes are evaluated using absolute expression while gene dosage effects are assessed using expression ratios, in both cases using non-parametric statistical tests. A more statistically robust approach is to employ linear mixed-effects modeling of gene expression. This provides a unified statistical framework to assess magnitude and significance of both chromosome-specific and dosage effects on gene expression. Moreover, it is applied directly to the sequencing read counts for each gene and incorporates scaling factors such as sequencing depth and transcript length into the models describing the data, as is done in most analyses of differential expression. As such, extensive normalization is avoided and statistical replicates are readily incorporated into the analysis. These methods will be implemented in a new software package, named "doseR", written in the R statistical programming language and distributed as part of the Bioconductor suite of bioinformatic software tools. Performance of the new statistical model and its software implementation relative to previous methods of assessing dosage compensation will be evaluated through extensive simulations of RNA-sequencing data. Application to specific empirical data sets relevant to dosage compensation will also be examined and evaluated. While the immediate motivation for software development is dosage compensation analysis, the proposed methodology can be employed in any analytical scenario requiring the detection of directional shifts in expression for multiple, specific subsets of genes. It therefore provides a tool with broad utility in systems biology research. Status and results of this project can be found at https://walterslab.github.io/doseR/.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.cub.2019.09.056
发表时间:
2019-12-02
期刊:
CURRENT BIOLOGY
影响因子:
9.2
作者:
[Gu, Liuqi, Reilly, Patrick F., Walters, James R.]
通讯作者:
Walters, James R.
The South Wales and South West England Mental Health Platform Hub
-
批准号:MR/Z503745/1
-
项目类别:Research Grant
-
资助金额:$471.84万
-
财政年份:2024
-
负责人:James Walters
-
依托单位:
Molecular Genetic Studies of Schizophrenia: Understanding Treatment Resistance and Outcomes to Inform Precision Psychiatry.
-
批准号:MR/Y004094/1
-
项目类别:Research Grant
-
资助金额:$283.05万
-
财政年份:2024
-
负责人:James Walters
-
依托单位:
DISSERTATION RESEARCH: Determining anucleated sperm function in Lepidoptera
-
批准号:1701931
-
项目类别:Standard Grant
-
资助金额:$1.97万
-
财政年份:2017
-
负责人:James Walters
-
依托单位:
Constraints on the evolution of chromosome dosage compensation: a test in butterflies and moths
-
批准号:1457758
-
项目类别:Continuing Grant
-
资助金额:$71.1万
-
财政年份:2015
-
负责人:James Walters
-
依托单位:
NSF Postdoctoral Research Fellowships in Biology for FY 2009
-
批准号:0905698
-
项目类别:Fellowship
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:James Walters
-
依托单位:
Genetic susceptibility to a deficit in context processing across the schizophrenia / bipolar disorder diagnostic divide.
-
批准号:G0601635/1
-
项目类别:Fellowship
-
资助金额:$34.5万
-
财政年份:2007
-
负责人:James Walters
-
依托单位:
Rapid In-Site Remediation of Hazardous Waste Sites Using Surfactant Biotechnology
-
批准号:9106202
-
项目类别:Continuing Grant
-
资助金额:$9.0万
-
财政年份:1991
-
负责人:James Walters
-
依托单位:
海外基金